Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2003
10/29/2003CN1451437A Staphlococcus aureus preparation and producting method thereof
10/29/2003CN1451436A Use of lysozyme and relative pure deriv. or raw liquid for preventing and treating diseases in sea and frech-water breeding
10/29/2003CN1451434A Chinese medicine for preventing and treating SARS virus
10/29/2003CN1451429A Chinese medicine for treating bacillary dysentery and producing method thereof
10/29/2003CN1451404A Medicine for treating bone tuberculosis
10/29/2003CN1451398A Serial Chinese medicine products for preventing and treating Aids
10/29/2003CN1451386A Rifaximin soft capsule composition
10/29/2003CN1125823C Ganciclovir sodium hydrate and its preparing process and application
10/29/2003CN1125819C Triazole alcohol antifungal compound and its preparation method
10/29/2003CN1125653C Pharmaceutical formulations containing voriconazole
10/29/2003CN1125641C Hongkong foot treating ointment
10/29/2003CN1125637C Application of 5,3',5'-trihydroxy-7-methoxyl dihydroflavone in preparing medicine
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638955 Antibiotic oxazolidinone derivatives
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638932 Derivatives having HIV replication inhibiting properties. The present compounds differ from the known 1,3,5-triazines by structure and by their improved HIV replication inhibiting properties.
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638919 Antiviral purine derivatives
10/28/2003US6638767 Methods for delivering compounds into a cell
10/28/2003US6638531 Peptide antibiotics for resistant bacteria; fungicides
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003US6638514 Immunogenic attenuated dengue viruses produced by serial passage in primary dog kidney cells
10/28/2003US6638511 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
10/28/2003US6638505 For prevention of influenza virus binding to cells, therapy of schizophrenia and diagnosing chronic viral disease associated with development of cancer
10/28/2003US6638500 Polyol-IFN-βconjugates modified at Cys-17 and composition containing same
10/28/2003CA2283939C Non-antigenic branched polymer conjugates
10/28/2003CA2213099C S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleoside complexes as potent inhibitors of hiv-replication
10/28/2003CA2105486C Therapeutic nucleosides
10/23/2003WO2003087371A1 Antiviral therapy on the basis of rna interference
10/23/2003WO2003087319A2 Carcinoembryonic antigen cell adhesion molecule 1 (ceacam1) structure and uses thereof in drug identification and screening
10/23/2003WO2003087298A2 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087126A2 Heteroclitic analogs and related methods
10/23/2003WO2003087121A1 Branched polyamine steroid derivatives
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087106A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents
10/23/2003WO2003087105A1 INHIBITORS OF SERINE AND METALLO-ß-LACTAMASES
10/23/2003WO2003087098A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087072A1 Therapeutic agent for endothelial disorder
10/23/2003WO2003087055A1 Improved cc-1065 analog synthesis
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003086473A1 Mycoplasma polypeptides
10/23/2003WO2003086466A1 Novel thrombomodulin expression promoters
10/23/2003WO2003086459A1 Methods of treatement using ctla-4 antibodies
10/23/2003WO2003086454A1 Antigen-loaded chitosan microparticles for oral vaccination
10/23/2003WO2003086453A1 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
10/23/2003WO2003086442A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally occuring plant compounds, extracts and derivatives
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086417A1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system
10/23/2003WO2003086412A2 Polyphosphonate derivatives for toothpaste compositions
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086389A1 Use of a photosensitising compound for the preparation of a pharmaceutical composition for treating of burns, and a method of treating burns
10/23/2003WO2003086381A1 Ansamycin formulations and methods for producing and using same
10/23/2003WO2003086367A1 Low dose liquid entecavir formulations and use
10/23/2003WO2003086354A1 Nanoparticulate megestrol formulations
10/23/2003WO2003086344A1 Antibiotic product, use and formulation thereof
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086319A2 Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086277A2 Attenuated gram negative bacteria
10/23/2003WO2003086097A1 Composition for modulating a physiological reaction or inducing an immune response
10/23/2003WO2003086093A1 Cheese capable of disinfecting helicobacter pylori
10/23/2003WO2003059343A3 Drug compositions with indole alkaloids for the treatment of aids
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003051124A3 Inhibition of the asexual reproduction of fungi
10/23/2003WO2003047619A3 Adjuvanted antigenic meningococcal compositions
10/23/2003WO2003043966A3 Clusianon isomers and use thereof
10/23/2003WO2003029410A3 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
10/23/2003WO2003027094A3 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
10/23/2003WO2003008576A3 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression
10/23/2003WO2003002064A3 Fused pyrimidine dhfr inhibitors as antibacterials
10/23/2003WO2003000922A3 Chimeric immunomodulatory compounds and methods of using the same
10/23/2003WO2002100895A3 Antimicrobially active peptide
10/23/2003WO2002083708A3 Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002081483A3 Inhibitors of acyl glucosaminyl inositol amidase and methods of use
10/23/2003WO2002062380A3 Chlamydia vaccine composition
10/23/2003WO2002047720A3 Treatment and prevention of ebv infection and ebv-associated disorders
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2002044321A3 Rna interference mediating small rna molecules
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2002036617A3 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine
10/23/2003WO2001096376A9 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
10/23/2003WO2001055337A9 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/23/2003WO2001047562A8 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
10/23/2003WO2001015680A8 Composition for treatment of infections of humans and animals
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003WO2001000812A8 22012, a novel human carboxypeptidase
1 ... 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 ... 1798